Latest
Moneycontrol.com Market update
Current financial headlines
Sharemaestro Newsreel
Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.
- Showing
- 1–28
- Headlines
- 28
- Sources here
- 14
- Companies here
- 4
Current section
India Drug Manufacturers - General news
Chronological news
Latest headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
How Pfizer’s Higher 2026 Guidance And LITFULO Trial Results At Pfizer (PFE) Have Changed Its Investment Story
In early August 2026, Pfizer Inc. reported second-quarter results showing revenue of US$15,034 million and a net loss of US$248 million, alongside US$4.30 billion in non-cash intangible asset impairments and a modest increase in full-year 2026 revenue guidance to US$60.50–US$62.50 billion. A key offsetting …
PFIZER
main company
Sharemaestro market context
Price above Trend Line
52 weeks -8.4%
5 Insightful Analyst Questions From Pfizer’s Q2 Earnings Call
5 Insightful Analyst Questions From Pfizer's Q2 Earnings Call Pfizer's second quarter results reflected stability in its core business despite ongoing challenges in COVID-related product demand. The company's performance was shaped by strong execution in its non-COVID portfolio, with management highlighting robust revenue contributions …
PFIZER
main company
Sharemaestro market context
Price above Trend Line
52 weeks -8.4%
Pfizer (PFE) Agreed To A $44 Million Chantix Settlement
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Pfizer (NYSE:PFE) agreed to a US$44 million class action settlement related to its smoking cessation drug Chantix, addressing claims tied to product safety disclosures. …
PFIZER
main company
Sharemaestro market context
Price above Trend Line
52 weeks -8.4%
Pfizer (PFE) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 11:00 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer - Albert Bourla Chief Financial Officer - David Denton Incoming Interim Chief Financial Officer and Executive Vice President - Cecile Guegan Chief Scientific …
PFIZER
main company
Sharemaestro market context
Price above Trend Line
52 weeks -8.4%
Pfizer Inc. (PFE) vs. BioNTech SE (BNTX): Which Pharma Giant Is Better Positioned for the Post-COVID Era?
Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX), two companies forever linked by their historic COVID-19 vaccine partnership, reported Q2 2026 earnings alongside major strategic announcements. While the European Commission authorized their updated XFG-adapted COVID-19 vaccine on July 29, the two partners are traveling down …
PFIZER
main company
Sharemaestro market context
Price above Trend Line
52 weeks -8.4%
Insider trades: Microsoft, Meta, Pfizer among notable names
[Meta European head office] Derick Hudson Insider transactions were seen across major firms this week, including Microsoft (MSFT [https://seekingalpha.com/symbol/MSFT]) and Meta (META [https://seekingalpha.com/symbol/META]). The following trades took place between August 3 and August 7. * Microsoft (MSFT [https://seekingalpha.com/symbol/MSFT]) saw two executives divest a small …
PFIZER
main company
Sharemaestro market context
Price above Trend Line
52 weeks -8.4%
Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound
Key Points Pfizer's berobenatide appears to be a promising candidate that could challenge Wegovy and Zepbound. There are several other reasons to consider the stock, despite the potential headwinds ahead. 10 stocks we like better than Pfizer › The past few years have been …
PFIZER
main company
Sharemaestro market context
Price above Trend Line
52 weeks -8.4%